Joshua Whitehill is an associate in the firm’s Litigation Department and a member of its Intellectual Property Group. Mr. Whitehill focuses his practice on patent matters, with a concentration in the areas of biotechnology and pharmaceuticals. He joined Goodwin in 2010.

Experience

Erfahrung

工作经历

Mr. Whitehill has participated in all phases of patent litigation, including pre-suit investigations, fact and expert discovery, trial and appeals to the Federal Circuit. Mr. Whitehill also has experience in preparing patent opinions (invalidity and clearance).

Representative matters include:

  • Pfizer Inc. et al. v. Teva Pharmaceuticals USA, Inc., No. 2:10-cv-00128-RBS-FBS (E.D. Va.). Representing Teva in patent infringement litigation filed by Pfizer under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of Pfizer’s VIAGRA® (sildenafil citrate) drug products.
  • Momenta Pharmaceuticals, Inc. et al. v. Teva Pharmaceuticals USA, Inc., No. 10-12079-NMG (D. Mass). Representing Teva in patent infringement litigation filed by Momenta and Sandoz concerning Teva’s generic version of Sanofi’s LOVENOX® (enoxaparin sodium) drug product.
  • ViiV Healthcare UK Ltd. et al. v. Teva Pharmaceuticals USA, Inc., No. 11-576-RGA (D. Del.). Representing Teva in patent infringement litigation filed by ViiV under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of ViiV’s EPZICOM® (abacavir sulfate and lamivudine) drug products.
  • Janssen Products, L.P. et al. v. Lupin Limited et al., No. 10-5954-WHW (D.N.J.). Representing Teva in patent infringement litigation filed by Janssen, the University of Illinois, and the United States Government under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of Janssen’s PREZISTA® (darunavir) drug products.
  • In re Bendamustine Consolidated Cases, No. 13-2046-GMS (D. Del.). Representing Cephalon in consolidated patent infringement litigations under the Hatch-Waxman Act against numerous generic pharmaceutical companies seeking approval to market generic versions of Cephalon’s TREANDA® (bendamustine hydrochloride) drug products.
  • Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., No. 14-874-SLR-SRF (D. Del.). Representing Teva in patent infringement litigation filed by Merck under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of Merck’s NASONEX® (mometasone furoate monohydrate) drug products.
  • AstraZeneca Pharmaceuticals LP et al. v. Teva Pharmaceuticals USA, Inc., No. 14-1478-GMS (D. Del.). Representing Teva in patent infringement litigation filed by AstraZeneca under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of AstraZeneca’s BYETTA® (exenatide) drug products.
Professional Activities

Mr. Whitehill is a contributor to the firm’s Biosimilars Reference Guide and biosimilars blog, www.bigmoleculewatch.com.

Mr. Whitehill is a member of the New York Intellectual Property Law Association (NYIPLA), including its publications and patent litigation committees.

Mr. Whitehill’s pro bono work includes representing a U.S. Army veteran in pursuing appeals related to his claims for disability benefits.

Professional Experience

Prior to joining Goodwin, Mr. Whitehill worked as a paralegal and law clerk at Cooper & Dunham LLP, where he was involved in all aspects of U.S. patent prosecution and PCT international filings, particularly in the areas of pharmaceuticals, biologics and medical devices.

Recognition

While attending law school, Mr. Whitehill was a Notes and Comments Editor for the Brooklyn Journal of International Law.

In The News

In den Nachrichten

在新闻中

Credentials

Anmeldeinformationen

专业资格

Education

J.D., 2009
Brooklyn Law School

(cum laude)

B.A., Chemistry, 2004
New York University

Admissions

Bar

New York

Courts

U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of New York
Get In Touch
In Kontakt kommen
Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.
Search Other Lawyers
Suche Andere Rechtsanwälte
搜寻其他律师